Synovial Fluid Crystal Interpreter
Synovial Fluid Crystal Interpreter
Needle-shaped and negatively birefringent is urate; rhomboid and positively birefringent is calcium pyrophosphate. That part is straightforward. The two things that catch people out are that finding a crystal does not exclude a septic joint — the two coexist in about one in twenty crystal arthritides — and that a normal serum urate during an attack does not exclude gout.
Monosodium urate or calcium pyrophosphate — and is that the whole answer?
Crystal type + count + Gram stain → interpretationA 71-year-old presents with an acutely swollen, hot knee and a temperature of 37.8 °C. The aspirate is turbid: white cell count 62,000 cells/mm³ with a neutrophil predominance, and compensated polarised light microscopy shows needle-shaped, strongly negatively birefringent crystals. The Gram stain has not been reported. There are no prosthetic joints and no immunosuppression.
Reading the sign against the compensator
Calcium pyrophosphate: rhomboid, parallelepipedal or rod-shaped, mostly 3–7 µm. Positively birefringent, magnitude about 0.015 — twenty times weaker, and often faint or apparently absent at small crystal size. Blue when the long axis is parallel to the compensator’s slow axis, yellow when perpendicular.
The common description of calcium pyrophosphate as weakly or non-birefringent is about detectability, not physics: all CPP crystals are positively birefringent, and the small ones are simply too faint to see against the background.
Worked example
A 71-year-old presents with an acutely swollen, hot knee and a temperature of 37.8 °C. The aspirate is turbid: white cell count 62,000 cells/mm³ with a neutrophil predominance, and compensated polarised light microscopy shows needle-shaped, strongly negatively birefringent crystals. The Gram stain has not been reported. There are no prosthetic joints and no immunosuppression.
Gram stain not back, so the first rule does not apply
White cell count 62,000 cells/mm³ — above 50,000, which is the conventional septic range
Needle-shaped and negatively birefringent is monosodium urate, and in a symptomatic joint that is the sufficient criterion for gout in the 2015 ACR/EULAR criteria. The crystal result is not in doubt
But the crystal result does not answer the other question. Concomitant infection occurs in about 5% of crystal arthritides, and a raised count is only 48.3% specific for it
Action: treat both. Gram stain, culture and blood cultures; empirical antibiotics if the patient is systemically unwell; drainage or washout per local practice; and treat the gout flare in parallel
Change one entry and the page changes with it. Drop the count to 20,000 and the same urate crystals read as straightforward gout — with the caveat still printed, because three of the twenty-two combined cases in Papanicolas' series had counts below 10,000
Monosodium urate against calcium pyrophosphate
| Feature | Monosodium urate | Calcium pyrophosphate |
|---|---|---|
| Shape | Needles up to about 30 µm, and shorter rods | Rhomboid, parallelepipedal or rod, mostly 3–7 µm |
| Sign of birefringence | Negative | Positive |
| Magnitude | About 0.30 — very bright, almost always obvious | About 0.015 — twenty times weaker, often faint |
| Colour when parallel to the compensator’s slow axis | Yellow | Blue |
| Colour when perpendicular | Blue | Yellow |
| What finding them means | Sufficient criterion for gout (2015 ACR/EULAR) | Sufficient criterion for CPPD (2023 ACR/EULAR) |
| What NOT finding them means | Scores −2 in the classification criteria; does not exclude gout, and crystals dissolve in stored fluid | Very little — the 2023 criteria note a high false-negative rate and high interobserver variability |
| Rate of coexisting infection | About 4% of affected joints | About 7.3% of affected joints |
Two things a positive result does not tell you
| Assumption | What the evidence says | What to do instead |
|---|---|---|
| Crystals mean it is not septic | 5% of crystal arthritides had concomitant infection; 3 of 22 combined cases had counts below 10,000/mm³; a raised count is 86.4% sensitive but only 48.3% specific for coexisting infection | Send Gram stain and culture regardless. Treat both where there is fever, a prosthetic joint, immunosuppression or a recent injection |
| A normal serum urate excludes gout | The 2015 ACR/EULAR criteria direct that urate be measured beyond 4 weeks from the start of an episode, and that a value below 4 mg/dL measured in an attack be repeated outside it | Diagnose on the crystals. If urate is needed for management, measure it once the flare has settled. The uric acid unit converter handles the unit |
| No crystals means no crystal disease | The 2023 ACR/EULAR CPPD criteria note a high false-negative rate and high interobserver variability for synovial fluid analysis; urate crystals dissolve in stored fluid | Re-examine fresh fluid, and look for chondrocalcinosis or a double-contour sign on imaging |
The sign is easy. What the result is allowed to conclude is not.
Crystal identification under compensated polarised light is one of the few bedside-adjacent tests in rheumatology that gives a definitive answer. Monosodium urate crystals in a symptomatic joint are the sufficient criterion in the 2015 ACR/EULAR gout classification criteria — no scoring is required once they are seen — and calcium pyrophosphate crystals in a symptomatic joint are the equivalent in the 2023 ACR/EULAR criteria for calcium pyrophosphate deposition disease. The discrimination rests on the sign of birefringence read against a first-order red compensator: urate is negatively birefringent and appears yellow when its long axis lies parallel to the compensator’s slow axis, calcium pyrophosphate is positively birefringent and appears blue in the same orientation.
The physics behind the difficulty is worth knowing, because it explains why the two are not equally easy to find. Urate’s birefringence has a magnitude of about 0.30 and calcium pyrophosphate’s about 0.015 — twenty times weaker — and calcium pyrophosphate crystals are mostly three to seven micrometres long against urate needles that reach thirty. The familiar description of calcium pyrophosphate as weakly or non-birefringent is therefore a statement about detectability rather than about the crystal: all of them are positively birefringent, and the small ones are simply too faint to distinguish from the background. That is also why the 2023 classification criteria bother to include imaging and clinical domains at all, and why they say explicitly that synovial fluid crystal analysis has a high false-negative rate and high interobserver variability.
The more dangerous problem is at the other end. A positive crystal result feels like a closed case, and it is not. In a series of 295 patients with crystal-proven arthritis, five per cent of affected joints had a concomitant infection — around seven per cent of those with calcium pyrophosphate crystals and around four per cent of those with urate. The synovial white cell count does not rescue the situation: three of the twenty-two patients with combined crystal and septic arthritis had counts below ten thousand cells per cubic millimetre, and in that series a raised count was 86.4 per cent sensitive but only 48.3 per cent specific for a coexisting infection. So the crystals are real, the diagnosis of crystal arthritis is correct, and the joint may still be infected. Culture is what answers that, and it takes days.
The third trap is the serum urate, and it is a trap because the test is cheap and available and the crystal examination often is not. Urate falls during an acute gout flare, and the 2015 classification criteria deal with this by directing that the measurement be taken outside an episode — ideally beyond four weeks from its start, and off urate-lowering therapy — and by instructing that a value below 4 mg/dL measured during an attack be repeated later. A normal or low serum urate in a patient with an acutely inflamed first metatarsophalangeal joint is therefore not evidence against gout; it is a measurement taken at the wrong time. Diagnose on the fluid, and measure the urate when it will mean something.
Frequently asked questions
How do you tell urate crystals from calcium pyrophosphate crystals?
By shape and by the sign of birefringence against a compensator. Monosodium urate crystals are needles up to about 30 µm, strongly negatively birefringent, and appear yellow when the long axis lies parallel to the compensator’s slow axis and blue when perpendicular. Calcium pyrophosphate crystals are rhomboid, parallelepipedal or rod-shaped, mostly 3–7 µm, positively birefringent, and appear blue when parallel and yellow when perpendicular. The magnitudes differ twenty-fold — about 0.30 against about 0.015 — which is why urate crystals are almost always obvious and calcium pyrophosphate crystals are often faint.
Do crystals in the joint fluid exclude septic arthritis?
No. In a series of 295 patients with crystal arthritis, 5% of affected joints had a concomitant infection — about 7.3% of those with calcium pyrophosphate crystals and about 4% of those with urate. The white cell count does not settle it either: three of the twenty-two patients with combined disease had counts below 10,000 cells/mm³, and a raised count was 86.4% sensitive but only 48.3% specific for coexisting infection. Send Gram stain and culture whatever the crystals show, and treat both where there is fever, a prosthetic joint, immunosuppression or a recent injection.
Does a normal serum urate rule out gout?
No, and measuring it during an attack is the reason people think it might. The 2015 ACR/EULAR gout classification criteria direct that serum urate be measured ideally when the patient is not taking urate-lowering therapy and beyond four weeks from the start of an episode, and they instruct that a value below 4 mg/dL measured during an attack be repeated outside one. Urate crystals in a symptomatic joint are the sufficient criterion and no urate value overrides them. The uric acid unit converter converts between µmol/L and mg/dL if your result is in the other unit.
The laboratory saw no crystals. Does that exclude crystal arthritis?
No, and the classification criteria say so. A negative synovial fluid analysis scores −2 in the 2015 gout criteria rather than excluding the diagnosis, and the 2023 calcium pyrophosphate criteria state explicitly that synovial fluid crystal analysis has a high false-negative rate and high interobserver variability. Two practical causes: calcium pyrophosphate crystals are small and twenty times less birefringent than urate, so they are genuinely easy to miss, and urate crystals dissolve in fluid that has been stored or refrigerated. Re-examine fresh fluid, and look for chondrocalcinosis on plain films or a double-contour sign on ultrasound.
What if both crystal types are reported in the same joint?
That is mixed crystal deposition and it is well described, particularly in older patients with chronic kidney disease or long-standing osteoarthritis. It is not usually a reporting error and it does not need resolving before treatment: the acute management of both is a non-steroidal anti-inflammatory, colchicine or a corticosteroid chosen on renal function and comorbidity. The long-term management does differ, since urate-lowering therapy treats gout and does nothing for calcium pyrophosphate disease, and calcium pyrophosphate deposition carries metabolic associations — haemochromatosis, hyperparathyroidism, hypomagnesaemia, hypophosphatasia — worth screening for in anyone under 60.
Could the crystals be something other than urate or calcium pyrophosphate?
Yes, and three alternatives account for most of the confusion. Corticosteroid crystals from a previous intra-articular injection are variably birefringent and can mimic either type, so the injection history matters. Cholesterol crystals are large flat rectangular plates with a notched corner and are found in chronic effusions — the same crystal that defines a pseudochylous effusion, covered in the chylous effusion interpreter. And calcium oxalate crystals occur in patients on long-term dialysis. If the report gives crystals without a birefringence sign, ask for a re-examination rather than assuming which type was meant.
Related calculators
References
- Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789–1798.
- Abhishek A, Tedeschi SK, Pascart T, et al. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. Arthritis Rheumatol. 2023;75(10):1703–1713.
- Papanicolas LE, Hakendorf P, Gordon DL. Concomitant septic arthritis in crystal monoarthritis. J Rheumatol. 2012;39(1):157–160.
- Niessink T, Jansen TL, Kleinherenbrink M, Janssen M, Otto C. Synovial fluid analysis with compensated polarization light microscopy: a physics approach to quantitative understanding of birefringence, polarization, and Maltese crosses. Clin Rheumatol. 2024;43(11):3597–3602.
Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.